India to Canada: Rivaroxaban Export Trade Route

The India to Canada Rivaroxaban corridor is one of India's established pharmaceutical export routes, with 77 shipments documented worth a combined $3.2M USD. The route is dominated by APOTEX RESEARCH PRIVATE LIMITED, which alone accounts for roughly 72% of all export value, reflecting the consolidated nature of India's rivaroxaban manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $41.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 78% of all shipments, consistent with rivaroxaban's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 30.8%, placing it at rank #9 among India's top rivaroxaban export destinations globally.

On the import side, key buyers of Indian rivaroxaban in Canada include APOTEX INC, APOTEX INC,, APOTEX INC,-4100 WESTON ROAD and 8 others. APOTEX INC is the single largest importer with 27 shipments valued at $1.3M USD.

India's rivaroxaban exports to Canada are driven primarily by a handful of large-scale manufacturers. APOTEX RESEARCH PRIVATE LIMITED with 54 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — APOTEX RESEARCH PRIVATE LIMITED, DR REDDY S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — together account for 93% of total trade value on this route. The average shipment value of $41.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo-rivaroxaban fct 20mg 100 btl 68679/771313254212 batch lot :- va7459 and apo-rivaroxaban fct 20mg 100 btl 68679/ 771313254212 vg2010, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX INC is the largest importer with 27 shipments worth $1.3M USD — representing 40% of all rivaroxaban imports from India on this route. A total of 11 buyers are active on this corridor.